Table 2.

First-line therapy in MM patients with detectable CPCs on peripheral blood smear at diagnosis

	N (%)
Cytotoxic chemotherapy*	102 (58)
PI-based	37 (21)
IMID-based	7 (4)
IMID + PI	17 (10)
Other	6 (3)
No treatment	6 (3)
NA	1 (1)
Hematopoietic stem cell transplant	39 (22)
Autologous	34 (19)
Allogeneic	5 (3)

*This included any cytotoxic agent(s) given in combination, but without a PI or IMID; PI, IMID and IMID + PI indicates these agent(s) given in combination, with or without cytotoxic chemotherapy

IMID immunomodulatory agent, NA not available, PI proteasome inhibitor